Racial differences and geographic variations in oral anticoagulation treatment among Medicare patients with non-valvular atrial fibrillation
Our study showed differences in the use of OACs across US counties and among various racial groups. These disparities highlighted the areas of unmet need for both Black and White patients.
Authors
- Jenny Jiang (ORCID: https://orcid.org/0000-0003-0341-1385)
- Brett D. Atwater (ORCID: https://orcid.org/0000-0002-0468-3668)
- Nipun Atreja (ORCID: https://orcid.org/0000-0001-6953-3372)
- Virginia Noxon
- Larry R. Jackson (ORCID: https://orcid.org/0000-0002-0195-1081)
- Amiee Kang
- Dionne M. Hines
- Melissa Hagan (ORCID: https://orcid.org/0009-0004-6677-0662)
Institutions
- Pfizer (United States) (US)
- Clinical Research Institute (US)
- Bristol-Myers Squibb (United States) (US)
- STATinMED (United States) (US)
- Alaska Heart and Vascular Institute (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1371/journal.pone.0314345
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Duke University
- Inova Health System